deinrezept Logo
All Medications
Vaniqa
Gesichtsbehaarung

Vaniqa® cream (Eflornithine)

Prescription cream for the treatment of excessive facial hair (hirsutism) in women.

Prescription required
Quick navigation

What is Vaniqa?

Vaniqa® is a prescription cream with the active ingredient Eflornithin (11.5 %), which is used for the treatment of excessive facial hair (hirsutism) in women. It slows hair growth, but does not remove existing hair.

Hirsutism affects 5–15 % of all women and can be caused by hormonal disorders (e.g. PCOS), drugs or genetic predisposition. Vaniqa® is used in addition to mechanical hair removal methods (razing, waxing, laser).

Eflornithine was originally developed as an anti-parasis agent against sleep disease. The hair growth-inhibiting effect was discovered as a random side effect.

Active Ingredients & Mechanism of Action

Active ingredient: Eflornithin (11,5 % Creme)

Active mechanism:

  • Eflornithine irreversibly inhibits ornithine decarboxylase (ODC) in the skin
  • ODC is a key enzyme for polyamine synthesis
  • Polyamines are essential for cell division and hair growth
  • The inhibition slows hair growth

Clinical effect:

  • Slowing hair growth in treated area
  • Hair becomes thinner and brighter
  • Visible only after 4-8 weeks of regular application
  • In case of settling: Return to original hair growth within 8 weeks

Important: Vaniqa® does not remove hair. It only slows down the growth. Existing hair must continue to be removed mechanically.

Who is it suitable for?

Vaniqa® is suitable for:

  • Women aged 18 with milletutism (excessive facial hair)
  • As a supplement to hair removal methods
  • Regardless of the cause of milletutism

Advantages:

  • Simple local application
  • Hormone-free treatment
  • Can be combined with all hair removal methods
  • Good safety profile

Not suitable:

  • Children under 12 years
  • For men (not approved)
  • To other body regions (only allowed for the face)
  • Pregnancy (inappropriate data)

Available Dosages

Dosing:

  • Apply thin to the affected areas twice a day
  • At least 8 hours distance between applications
  • Assessment of treatment success after 4-8 weeks
  • In case of efficacy: continuous therapy necessary (effect only on continued use)

Application quantity:

  • In each case a large quantity of inherited per affected area
  • Apply only to face and adjacent chin areas

How to Take

Application: 1. Clean face and dry Two. Apply thin layer Vaniqa® to affected areas 3. Gently rub until the cream is drawn in 4. Allow to dry at least 5 minutes before applying sunscreen or makeup Five. Wash hands

Important notes:

  • Not for damaged, irritated or freshly shaved skin (at least 5 minutes waiting for shaving)
  • Not in the eyes or on mucous membranes
  • Remove hair with the desired method
  • No improvement after 4 months: Rethink therapy
  • After settling, hair growth returns within 8 weeks

Contraindications

**Vaniqa® must not be used at:* *

  • hypersensitivity to eflornithine or any other constituent
  • Children under 12 years

Preview at:

  • Pregnancy (no sufficient data)
  • Still time (not recommended)
  • Acne or other skin diseases on the face

Possible Side Effects

Family (1–10 %):

  • Acne-like skin changes
  • Burning, stealing at the job site
  • Skin dryness
  • Itching
  • Roasting (erythem)
  • Crawling, numbness

** Occasionally (0.1-1 %):* *

  • Skin rash
  • Folliculitis (hair infection)
  • Ingrown hair
  • Skin swelling

Selten:

  • Contact dermatitis
  • Rosazea-like dermatitis

** Most side effects are mild and temporary. With severe skin irritation, the application can be reduced or paused once a day.

Frequently Asked Questions

Is Vaniqa right for you?

A licensed doctor will review your information and issue a prescription if suitable. Discreet and secure.

Important Notice

This information does not replace medical advice. If you have questions about your health or the suitability of this medication, please consult a doctor or pharmacist.

Important Safety Information

This service operates under German pharmaceutical law (HWG). For risks and side effects, read the package leaflet and consult your doctor or pharmacist. All medications are dispensed from a licensed pharmacy in Germany.